Kilitch Drugs Stock Performance
as on March 27, 2026 at 9:31 pm IST
Day's Low
Day's High
₹137.00₹152.20
1.40%
Downside
9.54%
Upside

52 Week's Low
52 Week's High
₹137.00₹250.00
1.40%
Downside
79.92%
Upside

Kilitch Drugs share price movements today
- Previous Close
- ₹152.80
- Open
- ₹151.20
- Volume
- 61.14K
- Upper Circuit
- ₹183.35
- Lower Circuit
- ₹122.25
- Day's Low - High
- ₹137.00 - ₹152.20
- 52 Week Low - High
- ₹137.00 - ₹250.00
Kilitch Drugs Historical Returns
- 1 Month Return
- -52.77 %
- 3 Month Return
- -55.48 %
- 1 Year Return
- -55.29 %
- 3 Year Return
- + 4.73 %
- 5 Year Return
- + 88.18 %
Kilitch Drugs Fundamentals
as on March 27, 2026 at 4:01 pm IST
Market Cap
₹534.21 Cr
Return on Equity (ROE)
11.02
PE Ratio (TTM)
19.54
Return on capital employed (ROCE)
13.14
Industry PE ratio
40.67
Beta (LTM)
0.71
P/B Ratio
2.3
Dividend Yield
0PEG Ratio
10.39
Quarterly Earnings Growth YOY
-22.99
EPS (TTM)
7.58921362829001
Sector
Pharmaceuticals
Book Value
61.56
Technical Analysis
Bearish
View Technical Analysis
Kilitch Drugs Stock Valuation
as on March 27, 2026 at 4:01 pm IST
Kilitch Drugs in the last 5 years
Lowest (-986.00x)
July 3, 2019
Today (19.54x)
March 25, 2026
Industry (40.67x)
March 25, 2026
Highest (371.68x)
October 16, 2020
Today’s Price to Earnings Ratio: 19.54x
Kilitch Drugs (India) Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kilitch Drugs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 534.21 | 17.64% | 0.60 | 24 | 198 | |
| NA | 32.13 | 10.59% | 0.00 | NA | NA | |
| NA | 1,501.04 | -1.23% | 0.00 | NA | NA | |
| NA | 341.06 | -2.04% | 0.66 | 12 | 379 | |
| NA | 87.87 | 12.81% | 0.00 | 8 | 173 |
Market expectation of Kilitch Drugs Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
100.00%
Buy
0.00%
Hold
0.00%
Sell
Kilitch Drugs Stock’s Investor Sentiment and Interest
Search interest for Kilitch Drugs (India) Ltd Stock has increased by 63% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:63% versus previous 30 day period
Kilitch Drugs (India) Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Kilitch Drugs (India) Ltd Annual Profit & Loss
Figures in Rupees Crores
Kilitch Drugs (India) Ltd Cash Flow
Figures in Rupees Crores
Kilitch Drugs Corporate Actions
View detailed summary of the earnings and dividend history of Kilitch Drugs.
Kilitch Drugs (India) Ltd Earnings Results
Kilitch Drugs (India) Ltd’s net profit fell -25.67% since last year same period to ₹4.43Cr in the Q3 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -45.91% fall in its net profits since last 3-months.
Read More about Earnings ResultsKilitch Drugs (India) Ltd Dividends May,2019
In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 per share on 30 May 2019 - translating a dividend yield of 0.33%.
Read More about Dividends
Insights on Kilitch Drugs (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTRetail Holding Unchanged

Retail Investor holdings remained unchanged at 36.23% of holdings in Dec 2025 quarter
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 63.77% of holdings in Dec 2025 quarter
NO EFFECTAgainst Peers

In the last 3 years, Torrent Pharmaceuticals Ltd has given 179.8% return, outperforming this stock by 175.1%
NO EFFECTAgainst Peers

In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.9% return, outperforming this stock by 88.2%
NEGATIVE IMPACTPrice Dip

In the last 1 month, KILITCH stock has moved down by -52.8%
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, 8.19 Cr → 4.43 Cr (in ₹), with an average decrease of 45.9% per quarter
NEGATIVE IMPACTRevenue Fall

Revenue is down for the last 2 quarters, 55.58 Cr → 55.34 Cr (in ₹), with an average decrease of 0.4% per quarter
About Kilitch Drugs (India) Ltd
Revenue: ₹53.81Cr as on December 2025 (Q3 FY26)
Net Profit: ₹4.32Cr as on December 2025 (Q3 FY26)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
| Organisation | Kilitch Drugs (India) Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Mukund P Mehta |
| E-voting on shares | Click here to vote |
FAQs
What is Kilitch Drugs share price today?
Kilitch Drugs share price today stands at ₹138.95 as on at the close of the market. Kilitch Drugs share today touched a day high of ₹152.2 and a low of ₹137.
What is the 52 week high and 52 week low range for Kilitch Drugs share?
Kilitch Drugs touched a 52 week high of ₹250 and a 52 week low of ₹137. Kilitch Drugs share price today i.e. is closed at ₹138.95, which is -44.42% down from its 52 week high and 1.42% up from its 52 week low.
What is Kilitch Drugs's market capitalisation today?
Kilitch Drugs market capitalisation is ₹534.21 Cr as on .
How to buy Kilitch Drugs shares?
To buy Kilitch Drugs shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for KILITCH or Kilitch Drugs (India) Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Kilitch Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Kilitch Drugs trading volume today?
Kilitch Drugs trading volume is 61.14K as on . This means that 61.14K shares of Kilitch Drugs were bought and sold on the stock market during today's trading session.